IL-27-Ucp2-FoxO3 axis mediating the polarization of alternatively activated macrophages and ameliorating inflammatory pain
The Korean Journal of Pain · 01.04.2026 · 39 (2) · 221-245
DOI: 10.3344/kjp.25307 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Korean Journal of Pain, erschienen am 01.04.2026. Verfasst von Yi Ma und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Anesthesiology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
- Key Laboratory of Clinical Evaluation Technology for Medical Devices of Zhejiang Province, Zhejiang, China.
ORCID-Profile: Yi Ma, Shuyuan Gan, Yueying Zheng, Xianhui Kang, Shengmei Zhu
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Ma, Y., Gan, S., Zheng, Y., Kang, X., & Zhu, S. (2026). IL-27-Ucp2-FoxO3 axis mediating the polarization of alternatively activated macrophages and ameliorating inflammatory pain. The Korean Journal of Pain, 39(2), 221-245. https://doi.org/10.3344/kjp.25307
Vancouver
Ma Y, Gan S, Zheng Y, Kang X, Zhu S. IL-27-Ucp2-FoxO3 axis mediating the polarization of alternatively activated macrophages and ameliorating inflammatory pain. The Korean Journal of Pain. 2026;39(2):221-245. doi:10.3344/kjp.25307
BibTeX
@article{Ma2026,
author = {Ma, Yi and Gan, Shuyuan and Zheng, Yueying and Kang, Xianhui and Zhu, Shengmei},
title = {IL-27-Ucp2-FoxO3 axis mediating the polarization of alternatively activated macrophages and ameliorating inflammatory pain},
journal = {The Korean Journal of Pain},
year = {2026},
volume = {39},
number = {2},
pages = {221--245},
doi = {10.3344/kjp.25307}
}
EUVIMED